Medical devices, healthcare technology and the business of care
PMA approval · P080025

MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM

Medtronic Neuromodulation · Decision date Mar 14, 2011

MEDTECHLEDGER EXPLANATIONP080025

What did the FDA approve?

FDA record P080025 shows a March 14, 2011 approval for the Medtronic InterStim Therapy System. The stated indication is treatment of chronic fecal incontinence in patients who have failed or could not tolerate more conservative treatments.

The record identifies the device as an implanted electrical device intended for treatment of fecal incontinence, with product code QON and applicant Medtronic Neuromodulation. The source does not state whether this action is an original PMA or a supplement, and it contains no safety or effectiveness data.

FDA approval order statement

APPROVAL FOR THE MEDTRONIC INTERSTIM THERAPY SYSTEM. THE DEVICE IS INDICATED FOR THE TREATMENT OF CHRONIC FECAL INCONTINENCE IN PATIENTS WHO HAVE FAILED OR COULD NOT TOLERATE MORE CONSERVATIVE TREATMENTS.
Regulatory pathway
Original PMA
Clinical specialty
Gastroenterology, Urology
Decision date
Mar 14, 2011

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P080025
Regulatory pathway
Premarket approval application
Product code
QON
Decision code
APPR
Decision date
Mar 14, 2011
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implanted electrical device intended for treatment of fecal incontinence.

Product code
QON
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P080025 received

    Application receipt date recorded by FDA.

  2. P080025 · FDA decision

    APPR

  3. P080025/S352 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  4. P080025/S351 · Related supplement

    lnterStim Therapy System, Verify Evaluation System

  5. P080025/S353 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P080025/S354 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl

Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080025

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records